NDC 61314-238
Carteolol Hydrochloride
Carteolol Hydrochloride
Carteolol Hydrochloride is a Ophthalmic Solution in the Human Prescription Drug category. It is labeled and distributed by Sandoz Inc. The primary component is Carteolol Hydrochloride.
| Product ID | 61314-238_42565981-7e64-4080-8195-034fd5ca0565 |
| NDC | 61314-238 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Carteolol Hydrochloride |
| Generic Name | Carteolol Hydrochloride |
| Dosage Form | Solution |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 2000-01-05 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA075476 |
| Labeler Name | Sandoz Inc |
| Substance Name | CARTEOLOL HYDROCHLORIDE |
| Active Ingredient Strength | 10 mg/mL |
| Pharm Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |